Expedia's stock rose 16% to $200.63 a share, the stock's highest level since 2022. BofA Global Research analyst Justin Post reiterated a buy rating on Expedia and lifted his price target on the stock ...
Osteoarthritis disproportionally affects postmenopausal women, and a biological mechanism for why this occurs has been largely unkown, hindering development of effective treatments. That is in part ...